🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the safety of intravitreal aflibercept injection in the treatment...
Status
Completed
Location
Ophthalmic Consultants of Long Island
Start Date
2013-03
Trial ID
NCT01813773
Treatments Being Tested
To determine the efficacy of intravitreally (IVT) administered VEGF Trap-Ey...
Status
Completed
Location
Multiple Locations
Start Date
2013-02
Trial ID
NCT01783886
This is a phase 4 prospective, nonrandomized, open label, interventional cl...
Status
Completed
Location
Southeast Retina Center
Start Date
2015-06
Trial ID
NCT03340610
Treatments Being Tested
The primary objective of the study is to compare the efficacy of intravitre...
Status
Completed
Location
Regeneron Investigational Site
Start Date
2016-03-31
Trial ID
NCT02713204
Treatments Being Tested
This interventional study will evaluate the retinal vascular dynamics assoc...
Status
Completed
Location
Cole Eye Institute, Cleveland Clinic
Start Date
2015-08-18
Trial ID
NCT02503540
Treatments Being Tested
The primary objective of the study is to investigate the safety and tolerab...
Status
Completed
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT01997164
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of intravitr...
Status
Completed
Location
The Retina Institute
Start Date
2012-06
Trial ID
NCT01578720
Treatments Being Tested
This study will assess the efficacy and safety of intravitreally (IVT), i.e...
Status
Completed
Location
Multiple Locations
Start Date
2011-12
Trial ID
NCT01482910
Treatments Being Tested
The primary objective of the study is to assess the efficacy of intravitrea...
Status
Completed
Location
Regeneron Study Site
Start Date
2016-03-29
Trial ID
NCT02718326
Treatments Being Tested
To collect data reflecting the efficacy and safety of aflibercept with and ...
Status
Completed
Location
Multiple Locations
Start Date
2014-05-29
Trial ID
NCT02120950
Treatments Being Tested